Q/c Technologies, Inc. (QCLS) · Nov 20, 2026 · Material agreement

Q/C Technologies amends preferred terms, buys time—not cash

Maturity extended — Series H maturity: March 2, 2027 → September 2, 2027

Q/C Technologies formalizes preferred-stock amendments that extend maturity to September 2027, offering timing relief without fresh capital.

Q/C Technologies is a pre-revenue company shifting from legacy pharmaceuticals toward optical and quantum/laser-based computing, with its main challenge still funding development before commercial adoption.

The filing mainly formalizes an already disclosed financing accommodation. Q/C filed amendments to the Series G and Series H preferred-stock certificates and amended PharmaCyte’s Series G long-term warrants; the amendments became effective upon filing. 〔0〕

The clearest business benefit is more time, not more liquidity. The Series H preferred-stock maturity moves from March 2, 2027 to September 2, 2027. 〔1〕 That delays a major financing or repayment pressure point by six months, but this 8-K does not provide cash, reduce the preferred balance, or advance the optical-computing program.

The control and dilution mechanics are being adjusted, but the economic impact is not fully clear from this filing. The amendments change the amendment provisions and PharmaCyte-specific beneficial-ownership limits, while the warrant amendment retains a 49.99% ownership cap. 〔2〕 The filing does not disclose a new conversion price, cash consideration, or operating milestone tied to these changes.

This is not a fresh surprise. The maturity extension and related warrant exchange had already been disclosed in the November 16, 2026 quarterly filing, so today’s 8-K is chiefly the legal completion of that arrangement rather than a new change in the company’s operating story.

Bottom line: Q/C gets additional time before a preferred-stock maturity deadline, which helps near-term financial flexibility but does not solve the company’s pre-revenue funding and execution challenge. The filing is confirmation, not a meaningful reset of the business story.

What to watch next

Nasdaq bid-price compliance deadline, May 5, 2027

Original filing on SEC EDGAR

Q/C Technologies amends preferred terms, buys time—not cash | QCLS Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.